Piper Sandler are buyers of this biotech stock despite ongoing selloff

September 25, 2024 6:00 AM

Analysts at Piper Sandler remain buyers of Regeneron Pharmaceuticals shares, even after the stock saw a recent pullback of about ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found